Endocrine Journal
Online ISSN : 1348-4540
Print ISSN : 0918-8959
ISSN-L : 0918-8959
REVIEWS
Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas [Review]
Takuro HoriiIzuho Hatada
著者情報
ジャーナル フリー

2016 年 63 巻 3 号 p. 213-219

詳細
抄録
Clustered regularly at interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) nucleases, so-called CRISPR/Cas, was recently developed as an epoch-making genome engineering technology. This system only requires Cas9 nuclease and single-guide RNA complementary to a target locus. CRISPR/Cas enables the generation of knockout cells and animals in a single step. This system can also be used to generate multiple mutations and knockin in a single step, which is not possible using other methods. In this review, we provide an overview of genome editing by CRISPR/Cas in pluripotent stem cells and mice.
著者関連情報
© The Japan Endocrine Society
前の記事 次の記事
feedback
Top